Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden
· Delayed Price · Currency is SEK 0.5120
+0.0230 (4.70%)
Jul 4, 2025, 5:24 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 54.02 million as of July 3, 2025. Its market cap has decreased by -46.27% in one year.
Market Cap
54.02M
Enterprise Value
35.24M
Revenue
62.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has decreased from 62.49M to 54.02M, a decrease of -13.55%. That is a compound annual growth rate of -1.36%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 98.92B |
| Sectra AB | 67.83B |
| Getinge AB | 52.49B |
| Asker Healthcare Group AB | 39.84B |
| Medicover AB | 39.48B |
| Camurus AB | 38.36B |
| AddLife AB | 22.81B |
| Vimian Group AB | 22.01B |